Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Chronic Myelomonocytic Leukemia (CMML)
In a small portion of people, chronic myelomonocytic leukemia (CMML) is linked to a known risk factor, such as prior treatment with chemotherapy. But in most people, the cause of CMML is unknown.
Even though we still don’t know what causes CMML in most cases, researchers have made a lot of progress. They’ve begun to understand how certain changes in the DNA in bone marrow cells may cause CMML to develop.
Here is what we know so far about these gene changes and how they might cause CMML.
Cancer is caused by changes in the DNA inside our cells. This is true of all cancers, including CMML.
DNA is the chemical in our cells that makes up our genes. Our genes control how our cells work. Our DNA, which comes from both our parents, affects more than just how we look.
Some genes help control when our cells grow, divide to make new cells, or repair mistakes in DNA. Other genes cause cells to die when they’re supposed to. If these genes aren’t working correctly, it can cause cells to grow out of control.
For example:
Any of these types of DNA changes might cause cells to grow out of control, which could lead to cancer. To learn more, see Oncogenes, Tumor Suppressor Genes, and DNA Repair Genes.
Usually, mutations in several different genes inside bone marrow cells are needed before a person develops CMML.
Some of the changes most often seen in CMML cells include mutations in the NRAS, KRAS, JAK2, SETBP1, TET2, ASXL1, RUNX1, and SRSF2 genes.
In some types of cancer, gene mutations that increase a person’s risk can be passed down (inherited) from a parent. But inherited gene mutations do not seem to cause CMML. Instead, the gene mutations in CMML cells are acquired during a person’s lifetime.
In a small number of people, the acquired gene mutations in CMML cells might be the result of exposure to cancer-causing chemicals, like chemotherapy. But most often, the gene changes that lead to CMML seem to happen for no apparent reason.
Many of these gene changes are probably just random events that sometimes happen inside a cell, without having an outside cause. Gene changes inside cells can build up over a person’s lifetime, which might help explain why CMML largely affects older people.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
National Cancer Institute. Myelodysplastic/Myeloproliferative Neoplasms Treatment (PDQ) – Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/myeloproliferative/hp/mds-mpd-treatment-pdq on January 23, 2025.
Padron E. Chronic myelomonocytic leukemia: Management and prognosis. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/chronic-myelomonocytic-leukemia-management-and-prognosis on January 23, 2025.
Padron E, Gurbuxani S. Chronic myelomonocytic leukemia: Clinical features, evaluation, and diagnosis. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/chronic-myelomonocytic-leukemia-clinical-features-evaluation-and-diagnosis on January 23, 2025.
Last Revised: March 7, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.